Analysis of Skin Cancers from Xeroderma Pigmentosum Patients Reveals Heterogeneous UV-Induced Mutational Profiles Shaped by DNA Repair

Andrey A. Yurchenko(Inserm), Fatemeh Rajabi(Inserm), Tirzah Braz Petta Lajus(Universidade Federal do Rio Grande do Norte), Hiva Fassihi(Guy's and St Thomas' NHS Foundation Trust), Alan R. Lehmann(University of Sussex), Chikako Nishigori(Kobe University), Ismaël Padioleau(Inserm), Konstantin Gunbin(Inserm), Leonardo Panunzi(Inserm), Fanny Morice‐Picard(Centre Hospitalier Universitaire de Bordeaux), Pierre Laplante(Inserm), Caroline Robert(Inserm), Patricia Kannouche(Centre National de la Recherche Scientifique), Carlos Frederico Martins Menck(Universidade de São Paulo), Alain Sarasin(Centre National de la Recherche Scientifique), Sergey I. Nikolaev(Inserm)
bioRxiv (Cold Spring Harbor Laboratory)
October 14, 2022
Cited by 4Open Access
Full Text

Abstract

ABSTRACT Xeroderma pigmentosum (XP) is a genetic disorder caused by mutations in genes of the Nucleotide Excision Repair (NER) pathway (groups A-G) or in Translesion Synthesis (TLS) DNA polymerase η (V). XP is associated with an increased skin cancer risk, reaching, for some groups, several thousand-fold compared to the general population. Here, we analyzed 38 skin cancer genomes from five XP groups. We found that the activity of NER determines heterogeneity of the mutation rates across skin cancer genomes and that transcription-coupled NER extends beyond the gene boundaries reducing the intergenic mutation rate. Mutational profile in XP-V tumors and experiments with POLH -KO cell line revealed the role of polymerase η in the error-free bypass of (i) rare TpG and TpA DNA lesions, (ii) 3’ nucleotides in pyrimidine dimers, and (iii) TpT photodimers. Our study unravels the genetic basis of skin cancer risk in XP and provides insights into the mechanisms reducing UV-induced mutagenesis in the general population.


Related Papers

No related papers found

Powered by citation graph analysis